📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

BCR-ABL residues interacting with ponatinib are critical to preserve the tumorigenic potential of the oncoprotein. (2014)

First Author: Buffa P
Attributed to:  Rigorous Information-theoretic tools for Comparative Interactomics. funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1096/fj.13-236992

PubMed Identifier: 24297701

Publication URI: http://europepmc.org/abstract/MED/24297701

Type: Journal Article/Review

Volume: 28

Parent Publication: FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Issue: 3

ISSN: 0892-6638